JPH0630604B2 - Hyaluronic acid manufacturing method - Google Patents

Hyaluronic acid manufacturing method

Info

Publication number
JPH0630604B2
JPH0630604B2 JP61170943A JP17094386A JPH0630604B2 JP H0630604 B2 JPH0630604 B2 JP H0630604B2 JP 61170943 A JP61170943 A JP 61170943A JP 17094386 A JP17094386 A JP 17094386A JP H0630604 B2 JPH0630604 B2 JP H0630604B2
Authority
JP
Japan
Prior art keywords
hyaluronic acid
molecular weight
producing
culture
streptococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61170943A
Other languages
Japanese (ja)
Other versions
JPS6328398A (en
Inventor
照三 三好
広進 北川
晋 千葉
正道 橋本
治久 三枝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denka Co Ltd
Original Assignee
Denki Kagaku Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denki Kagaku Kogyo KK filed Critical Denki Kagaku Kogyo KK
Priority to JP61170943A priority Critical patent/JPH0630604B2/en
Publication of JPS6328398A publication Critical patent/JPS6328398A/en
Publication of JPH0630604B2 publication Critical patent/JPH0630604B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は発酵法によるヒアルロン酸(以下HAと省略す
る)の製造法に関し、化粧品又は医薬品用として望まれ
ている天然に存在するHAに近い高分子量のHAを製造
する方法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial field of application] The present invention relates to a method for producing hyaluronic acid (hereinafter abbreviated as HA) by a fermentation method, and is close to naturally occurring HA desired for cosmetics or pharmaceuticals. It relates to a method for producing high molecular weight HA.

〔従来の技術とその問題点〕[Conventional technology and its problems]

従来、HAはニワトリのトサカ、牛の眼の硝子体又は臍
帯等より抽出によって得られていた。しかし生体からの
分離精製は、夾雑タンパクやコンドロイチン硫酸等のム
コ多糖類の存在により複雑な工程を必要とする上に、生
体中のヒアルロニダーゼ等により分離・精製工程中に元
来高分子量であったHAが分解され低分子量化され、粘
度及び保温性が低くなるという欠点があった。そこでH
Aの分解を抑制してより高分子量のHAを得る方法が種
々考案されている(例えばファーマシア社製の商品名
“Healon”には極限粘度法により算出して分子量230
万のHAを使用)が、十分とは言い難く、また、そのた
めにコストアップの要因ともなっていた。これら欠点を
解決するものとしてHA生産能を有するストレプトコッ
カス属の微生物をグルコース、酵母エキス、ポリペプト
ン等の栄養源を含む液体培地中でpH7付近に調整しつ
つ好気的に培養し、培養液からHAを単離する方法が特
開昭58−56692号公報、特開昭60−133894号公
報、特開昭61−63294号公報等に開示されてい
る。これらの方法は抽出法に比較して単離・精製が簡単
でコストが安いという利点がある。しかしながら一般に
抽出法HAに比較し、発酵法により得られるHAは分子
量が低く(一般に150万以下)、HAの特徴である粘性
・保湿効果において劣るといわれているにもかかわら
ず、生体由来品に近い高分子量のヒアルロン酸を製造す
る方法は未だ見いだされていない。そのため、天然に近
い高分子量が要求される眼科・関節炎治療薬等の医薬用
途への利用が制限されていた。
Conventionally, HA has been obtained by extraction from chicken mackerel, vitreous or umbilical cord of bovine eyes. However, separation and purification from living organisms requires complicated steps due to the presence of mucopolysaccharides such as contaminating proteins and chondroitin sulfate, and in addition, it was originally high in molecular weight during the separation and purification steps by hyaluronidase in living bodies. There was a drawback that HA was decomposed and the molecular weight was lowered, and the viscosity and heat retention were lowered. So H
Various methods have been devised to obtain a higher molecular weight HA by suppressing the decomposition of A (for example, the trade name "Healon" manufactured by Pharmacia Co. has a molecular weight of 230 calculated by an intrinsic viscosity method).
However, it was difficult to say that it was sufficient, and it was also a factor of cost increase. As a solution to these drawbacks, a microorganism of the genus Streptococcus having HA-producing ability is aerobically cultivated in a liquid medium containing nutrient sources such as glucose, yeast extract and polypeptone while adjusting the pH to around 7, and HA is removed from the culture solution. Isolation methods are disclosed in JP-A-58-56692, JP-A-60-133894, JP-A-61-63294 and the like. These methods have the advantages that they are easier to isolate and purify and are cheaper than the extraction methods. However, compared with the extraction method HA, HA obtained by the fermentation method generally has a lower molecular weight (generally 1.5 million or less) and is said to be inferior in the viscosity and moisturizing effect, which are the characteristics of HA. No method has yet been found for producing hyaluronic acid of close high molecular weight. Therefore, its use in medicinal applications such as ophthalmology and arthritis remedies requiring a high molecular weight close to natural has been limited.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者らは、これらの問題点を解決すべく検討した結
果、培養液のpHをコントロールすることにより、発酵法
で高分子量のHAを取得できることを見い出し、本発明
を完成した。具体的には培養液のpHと蓄積されるヒア
ルロン酸の分子量との関連を詳細に検討した結果、培養
液pHを従来技術であるpH7の中性付近よりむしろア
ルカリ側に維持することで著しく高い分子量のヒアルロ
ン酸が蓄積されることを見いだした。
As a result of studies to solve these problems, the present inventors have found that a high molecular weight HA can be obtained by a fermentation method by controlling the pH of a culture solution, and completed the present invention. Specifically, as a result of detailed examination of the relationship between the pH of the culture solution and the molecular weight of the accumulated hyaluronic acid, it was remarkably high when the pH of the culture solution was maintained on the alkaline side rather than near neutrality of pH 7 which is the conventional technique. It was found that high molecular weight hyaluronic acid was accumulated.

すなわち本発明は、HA産生能を有するストレプトコッ
カス属の微生物を好気的に培養するにあたり、培養液の
pHを7.5以上9.0以下の範囲にコントロールすることによ
り、培養液中に高分子量のヒアルロン酸を生成蓄積せし
めることを特徴とする発酵法によるヒアルロン酸の製造
法である。
That is, the present invention, when aerobically culturing a microorganism of the genus Streptococcus having HA-producing ability,
A method for producing hyaluronic acid by a fermentation method, which comprises producing and accumulating high-molecular-weight hyaluronic acid in a culture solution by controlling pH in the range of 7.5 to 9.0.

以下本発明を詳しく説明する。The present invention will be described in detail below.

本発明に用いられるHA生産菌としては、 ストレプトコッカス エキ(Streptococcus equi) ストレプトコッカス ズーエピデミカス (Streptococcus zooepidemicus) ストレプトコッカス エキシミリス (Streptococcus equisimilis) ストレプトコッカス ディスガラクティエ (Streptococcus dysgalactiae) ストレプトコッカス ピオゲネス (Streptococcus pyogenes) などがあげられるが、なかでもストレプトコッカス エ
キが好ましい。また、これらの菌株から誘導された変異
株も使用できる。
Examples of the HA-producing bacterium used in the present invention include Streptococcus equi (Streptococcus equisimoces) and Streptococcus esculia dysgalactia (Streptococcus equisimilicus) Streptococcus esculia dysgalactia. However, Streptococcus equi is preferable. In addition, mutant strains derived from these strains can also be used.

本発明に用いる培地は通常の微生物の培養に用いるもの
で良く、グルコース、フラクトース、ガラクトース、シ
ュークロース等の炭素源、リン酸第1カリウム、リン酸
第2カリウム、硫酸マグネシウム、亜硫酸ソーダ、ナオ
硫酸ソーダ、リン酸アンモニウム等の無機塩類、ポリペ
プトン、カザミノ酸、酵母エキス、コーンスティープリ
カー、大豆加水分解液等の有機栄養源の他必要に応じて
各種アミノ酸、ビタミン類等が好適に用いられる。これ
らの培地成分は一括仕込又は分割添加いずれでも採用可
能である。
The medium used in the present invention may be one used for culturing ordinary microorganisms, and includes carbon sources such as glucose, fructose, galactose, and sucrose, primary potassium phosphate, secondary potassium phosphate, magnesium sulfate, sodium sulfite, and naosulfate. Inorganic salts such as soda and ammonium phosphate, polypeptone, casamino acid, yeast extract, corn steep liquor, organic nutrient sources such as soybean hydrolyzate, and various amino acids, vitamins and the like are preferably used if necessary. These medium components can be used either as a batch or as a divided addition.

本発明の培養は通気撹拌培養等の公知の方法でよく、培
養温度は30〜35℃が好ましい。
The culture of the present invention may be performed by a known method such as aeration and stirring culture, and the culture temperature is preferably 30 to 35 ° C.

培養液のpHは菌の生育と共に低下するため、カ性ソー
ダ、カ性カリ、アンモニア等のpH調整剤を添加しpH7.5
〜9.0好ましくはpH8.0〜8.7にコントロールすれば本発
明の目的を達成することができる。pHが7.5未満だと生
成HAの分子量が200万以下となり、pHが9.0を越え
るとHA生産菌の生育が著しく低下し、そのためHAの
収量が極めて低くなり好ましくない。
Since the pH of the culture solution decreases with the growth of the bacterium, pH adjusters such as caustic soda, caustic potash, and ammonia are added to pH 7.5.
~ 9.0, preferably pH 8.0 ~ 8.7 can achieve the object of the present invention. If the pH is less than 7.5, the molecular weight of the produced HA will be 2,000,000 or less, and if the pH exceeds 9.0, the growth of HA-producing bacteria will be remarkably reduced, resulting in an extremely low HA yield, which is not preferable.

このようにして培養すると、HAの生成と共に培養液の
粘度が次第に上昇してくる。使用炭素源が培養液中で消
費された時点で培養を停止し、遠心分離による除菌後、
アルコール等の有機溶媒による析出、限外ろ過による脱
塩等の簡単な公知精製法により高純度・高分子量HAが
得られる。
When culturing is performed in this manner, the viscosity of the culture solution gradually increases as HA is produced. When the carbon source used is consumed in the culture solution, the culture is stopped, and after sterilization by centrifugation,
High-purity, high-molecular-weight HA can be obtained by a simple known purification method such as precipitation with an organic solvent such as alcohol and desalting by ultrafiltration.

〔実施例〕〔Example〕

次に実施例により本発明を詳しく説明するが本発明はこ
れに限定されるものではない。
Next, the present invention will be described in detail with reference to examples, but the present invention is not limited thereto.

実施例1 グルコース2%,リン酸第1カリウム0.2%,硫酸マグ
ネシウム7水塩0.05%,ナオ硫酸ソーダ0.1%,ポリペ
プトン1.0%、酵母エキス0.5%からなるpH8.5の培養液
1に同一培地からなるストレプトコッカス エキ(AT
CC 9527)の前培養液10mを接種し、通気量1.
5vvm、撹拌200回転/分、温度33℃でカ性ソーダで
pHを8.5にコントロールしながら15時間培養した。
Example 1 From the same medium to a culture solution 1 of pH 8.5 consisting of glucose 2%, potassium potassium phosphate 0.2%, magnesium sulfate heptahydrate 0.05%, sodium naosulfate 0.1%, polypeptone 1.0% and yeast extract 0.5%. Streptococcus Exhaust (AT
CC 9527) inoculated with 10m of pre-cultured solution, aeration volume 1.
5 vvm, stirring 200 rpm, temperature of 33 ° C with caustic soda
The culture was carried out for 15 hours while controlling the pH to 8.5.

培養液を塩酸でpH4に調整後、蒸留水で2倍希釈し、遠
心分離により除菌した。得られた除菌液をエチルアルコ
ールを加えHAソーダを析出せしめる。これをろ別した
後水に溶解し、セチルピリジニウムクロライドを加え、
生じた沈澱をろ取し、水に再溶解後再びエチルアルコー
ルによる析出をくり返す。得られたHAソーダを室温で
減圧乾燥して培養1あたり1.8gの白色HAソーダを
得た。
The culture solution was adjusted to pH 4 with hydrochloric acid, diluted 2-fold with distilled water, and centrifuged to remove bacteria. Ethyl alcohol is added to the obtained sterilized solution to precipitate HA soda. After separating this by filtration, it is dissolved in water, cetylpyridinium chloride is added,
The formed precipitate is collected by filtration, redissolved in water, and precipitated again with ethyl alcohol. The obtained HA soda was dried under reduced pressure at room temperature to obtain 1.8 g of white HA soda per culture 1.

このHAソーダを0.2M塩化ナトリウム溶液として極限
粘度法により平均分子量を算出した。分子量は、日局一
般試験法28:粘度測定法により比粘度を測定し、各濃
度に対する還元粘度を次式で算出し、 還元粘度を縦軸に、対応する濃度(g/100m)を横
軸にとってグラフを書き、各点を結ぶ線の延長と縦軸の
交点を極限粘度〔η〕とし、次のWangの式〔R.Clel,J.
L.Wang,Biopolymer,,799(1970)〕 分子量M=(〔η〕/0.000228)1.225により算出した。
This HA soda was used as a 0.2 M sodium chloride solution, and the average molecular weight was calculated by the limiting viscosity method. The molecular weight is measured by the Japanese Pharmacopoeia General Test Method 28: Viscosity Measurement Method, and the reduced viscosity for each concentration is calculated by the following formula: A graph is drawn with the reduced viscosity on the vertical axis and the corresponding concentration (g / 100m) on the horizontal axis. The extension of the line connecting each point and the intersection of the vertical axis are the intrinsic viscosity [η], and the Wang's formula [R .Clel, J.
L. Wang, Biopolymer, 9 , 799 (1970)] Molecular weight M = ([η] /0.000228) 1.225 .

この結果、平均分子量は330万であった。As a result, the average molecular weight was 3.3 million.

比較例 培養時のpHをpH7.0とpH9.2にする以外は実施例1と同様
にした結果を比較例1、2として表1に示す。
Comparative Example Table 1 shows the same results as in Example 1 except that the pH during culture was set to pH 7.0 and pH 9.2.

実施例2 培養時のpHをpH8.0とpH9.0にする以外は実施例1と同様
に培養を開始し、培養液中の残存グルコース濃度が0.5
〜1%濃度になる様にグルコースを分添しつつ40時間
培養を続け、これらの培養液を実施例1と同様に処理し
HAソーダを得た。その結果を表2に示す。
Example 2 Culture was started in the same manner as in Example 1 except that the pH during the culture was adjusted to pH 8.0 and pH 9.0, and the residual glucose concentration in the culture solution was 0.5.
Culture was continued for 40 hours while adding glucose to a concentration of ˜1%, and these culture solutions were treated in the same manner as in Example 1 to obtain HA soda. The results are shown in Table 2.

〔発明の効果〕 以上に説明したように、本発明によれば、発酵法では従
来にない高分子量のHAを得ることができる。
[Effects of the Invention] As described above, according to the present invention, it is possible to obtain a high molecular weight HA which has not been obtained by the fermentation method.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 三枝 治久 東京都町田市旭町3丁目5番1号 電気化 学工業株式会社中央研究所内 審査官 谷口 博 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Haruhisa Saegusa 3-5-1 Asahimachi, Machida-shi, Tokyo Denka Kagaku Kogyo Co., Ltd. Central Research Laboratory Examiner Hiroshi Taniguchi

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】ヒアルロン酸産生能を有するストレプトコ
ッカス属の微生物を好気的に培養するにあたり、培養液
のpHを7.5以上9.0以下の範囲にコントロールすることに
より、培養液中に高分子量のヒアルロン酸を生成蓄積せ
しめることを特徴とする発酵法によるヒアルロン酸の製
造法。
1. When aerobically culturing a microorganism of the genus Streptococcus capable of producing hyaluronic acid, the pH of the culture broth is controlled to be in the range of 7.5 to 9.0, whereby high molecular weight hyaluronic acid is contained in the culture broth. A method for producing hyaluronic acid by a fermentation method, which comprises producing and accumulating.
【請求項2】培養液中に生成蓄積した高分子量のヒアル
ロン酸が極限粘度法による平均分子量で200万〜400万の
範囲のヒアルロン酸である特許請求の範囲第1項記載の
ヒアルロン酸の製造法
2. The production of hyaluronic acid according to claim 1, wherein the high molecular weight hyaluronic acid produced and accumulated in the culture medium is hyaluronic acid having an average molecular weight of 2,000,000 to 4,000,000 as determined by the limiting viscosity method. Law
【請求項3】ヒアルロン酸産生能を有するストレプトコ
ッカス属の微生物がストレプトコッカス エキ(Strept
ococcus equi)である特許請求の範囲第1項記載のヒア
ルロン酸の製造法
3. A microorganism belonging to the genus Streptococcus having hyaluronic acid-producing ability is Streptococcus equi (Strept.
ococcus equi) The method for producing hyaluronic acid according to claim 1.
JP61170943A 1986-07-22 1986-07-22 Hyaluronic acid manufacturing method Expired - Lifetime JPH0630604B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61170943A JPH0630604B2 (en) 1986-07-22 1986-07-22 Hyaluronic acid manufacturing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61170943A JPH0630604B2 (en) 1986-07-22 1986-07-22 Hyaluronic acid manufacturing method

Publications (2)

Publication Number Publication Date
JPS6328398A JPS6328398A (en) 1988-02-06
JPH0630604B2 true JPH0630604B2 (en) 1994-04-27

Family

ID=15914242

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61170943A Expired - Lifetime JPH0630604B2 (en) 1986-07-22 1986-07-22 Hyaluronic acid manufacturing method

Country Status (1)

Country Link
JP (1) JPH0630604B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7748388B2 (en) 2001-01-19 2010-07-06 Hironori Yamamoto Endoscopic injectable preparation

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897349A (en) * 1989-04-28 1990-01-30 Medchem Products, Inc. Biosynthesis of hyaluronic acid
JP2017112901A (en) * 2015-12-24 2017-06-29 キッコーマン株式会社 Method for producing high-molecular-weight hyaluronic acid

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0143393A2 (en) * 1983-11-25 1985-06-05 Miles Inc. The use of ultrapure hyaluronic acid to improve animal joint function
JPS60251898A (en) * 1984-05-25 1985-12-12 Shiseido Co Ltd Preparation of hyaluronic acid by fermentation method
JPS6115698A (en) * 1984-07-03 1986-01-23 Chisso Corp Preparation of hyaluronic acid
JPS6163293A (en) * 1984-09-04 1986-04-01 Chisso Corp Production of hyaluronic acid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0143393A2 (en) * 1983-11-25 1985-06-05 Miles Inc. The use of ultrapure hyaluronic acid to improve animal joint function
JPS60251898A (en) * 1984-05-25 1985-12-12 Shiseido Co Ltd Preparation of hyaluronic acid by fermentation method
JPS6115698A (en) * 1984-07-03 1986-01-23 Chisso Corp Preparation of hyaluronic acid
JPS6163293A (en) * 1984-09-04 1986-04-01 Chisso Corp Production of hyaluronic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7748388B2 (en) 2001-01-19 2010-07-06 Hironori Yamamoto Endoscopic injectable preparation

Also Published As

Publication number Publication date
JPS6328398A (en) 1988-02-06

Similar Documents

Publication Publication Date Title
FI79346C (en) FRAMSTAELLNING AV HYALURONSYRA MEDELST BAKTERIEKULTUR.
US9347079B2 (en) Production of highly purified sodium hyaluronate (HANa) with controlled molecular weight
CN102617754A (en) Efficient process for purification of high molecular weight hyaluronic acid
JPH09324001A (en) Purification method for sodium hyaluronate
US5071751A (en) Process for preparing hyaluronic acid
US4885244A (en) Method of producing hyaluronic acid
JPH0630605B2 (en) Method for producing sodium hyaluronate aqueous solution
JPS6394988A (en) Production of hyaluronic acid
JPH0630604B2 (en) Hyaluronic acid manufacturing method
JP3632197B2 (en) Method for producing high molecular weight hyaluronic acid or salt thereof
JPH062073B2 (en) Hyaluronic acid manufacturing method
JP3973312B2 (en) Method for producing hyaluronic acid by fermentation
JPH0753117B2 (en) Hyaluronic acid manufacturing method
Reddy et al. Enhanced hyaluronic acid production by a mutant strain, 3523-7 of Streptococcus zooepidemicus
JPH044868B2 (en)
JPH046356B2 (en)
JPH0443637B2 (en)
KR100258237B1 (en) Medium for culturing microorganisms producing hyaluronic acid
JPH0823992A (en) Production of hyaluronic acid
JPS61219394A (en) Production of hyaluronic acid through fermentation
JPS63129991A (en) Production of hyaluronic acid
JPH0746992A (en) Production of hyaluronic acid
JPS6163294A (en) Production of hyaluronic acid through fermentation process
JP2759394B2 (en) Method for producing purified xanthan gum
JPS62257901A (en) Production of hyaluronic acid

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090427

Year of fee payment: 15